Contact
QR code for the current URL

Story Box-ID: 1132507

Xenios AG Im Zukunftspark 1 74076 Heilbronn, Germany http://www.xenios-ag.com
Contact Ms Sandra Hubatschek +49 7131 2706388
Company logo of Xenios AG
Xenios AG

Fresenius Medical Care Heart & Lung enables ECMO simulation in virtual reality

VR app for extracorporeal heart and lung support at ESCIM LIVES 2022

(PresseBox) (Heilbronn, )
Fresenius Medical Care’s heart & lung division Xenios AG presents its virtual reality application at ESCIM LIVES congress in Paris. Visitors can discover a fictitious ECMO case and interactive hands-on experiences.  

Fresenius Medical Care’s heart & lung division Xenios AG is an expert in extracorporeal heart and lung support, specialized on products for extracorporeal membrane oxygenation (ECMO). ECMO treatment, used as “last rescue” procedure, is rarely performed on intensive care units (ICU) but mostly in so-called ECMO centers which are specialized in this form of treatment. Thus, intensive care physicians are often not familiar with this kind of treatment.

Therefore, there is a need to introduce physicians to this topic in a safe and easy-to-use digital environment. Virtual reality (VR) can help these physicians in getting first insights in ECMO treatment. With the help of VR goggles, procedures such as cannulation can be mimicked step-by-step, potentially overcoming existing hurdles.

Within a virtual ICU setting, Xenios shows a new perspective on ECMO treatments at ESICM LIVES congress in Paris. Based on a fictitious case, interested visitors can perform an ECMO procedure virtually with the use of VR googles or follow the simulation on a screen. 

Website Promotion

Website Promotion
ECMO treatments for patients suffering from cardiac and/or pulmonary failure

Xenios AG

At Xenios, a Fresenius Medical Care company, we offer treatments for patients suffering from cardiac and/or pulmonary failure. Based on a holistic understanding of human physiology, we develop intelligent technological solutions that can be vital for the survival of critically ill patients.

We offer solutions that combine both cardiac and pulmonary support on one single technological platform. It supports the gas exchange in the lungs and the cardiovascular system to keep patients alive. The physician thus gains more vital treatment time during diagnosis and therapy.

Xenios is part of Fresenius Medical Care, the world's leading provider of products and services for people with renal diseases. We are complementing Fresenius Medical Care’s product portfolio in the field of intensive care and are continuing to shape the future of extracorporeal multi-organ support.

In our daily work, we share a passion for helping people. For patients. Worldwide. Every day.

Visit the Xenios website:
www.xenios-ag.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.